Literature DB >> 21841260

Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.

Anna Zimny1, Pawel Szewczyk, Elzbieta Trypka, Renata Wojtynska, Leszek Noga, Jerzy Leszek, Marek Sasiadek.   

Abstract

The purpose of this study was to assess metabolic, perfusion, and microstructural changes within the posterior cingulate area in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) using advanced MR techniques such as: spectroscopy (MRS), perfusion weighted imaging (PWI), and diffusion tensor imaging (DTI). Thirty patients with AD (mean age 71.5 y, MMSE 18), 23 with aMCI (mean age 66 y, MMSE 27.4), and 15 age-matched normal controls (mean age 69 y, MMSE 29.5) underwent conventional MRI followed by MRS, PWI, and DTI on 1.5 Tesla MR unit. Several metabolite ratios (N-acetylaspartate [NAA]/creatine [Cr], choline [Ch]/Cr, myoinositol [mI]/Cr, mI/NAA, mI/Cho) as well as parameters of cerebral blood volume relative to cerebellum and fractional anisotropy were obtained in the posterior cingulate region. The above parameters were correlated with the results of neuropsychological tests. AD patients showed significant abnormalities in all evaluated parameters while subjects with aMCI showed only perfusion and diffusion changes in the posterior cingulate area. Only PWI and DTI measurements revealed significant differences among the three evaluated subject groups. DTI, PWI, and MRS results showed significant correlations with neuropsychological tests. DTI changes correlated with both PWI and MRS abnormalities. Of neuroimaging methods, DTI revealed the highest accuracy in diagnosis of AD and aMCI (0.95, 0.79) followed by PWI (0.87, 0.67) and MRS (0.82, 0.47), respectively. In conclusion, AD is a complex pathology regarding both grey and white matter. DTI seems to be the most useful imaging modality to distinguish between AD, aMCI, and control group, followed by PWI and MRS.

Entities:  

Mesh:

Year:  2011        PMID: 21841260     DOI: 10.3233/JAD-2011-110254

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Authors:  Burcu Zeydan; Dinesh K Deelchand; Nirubol Tosakulwong; Timothy G Lesnick; Orhun H Kantarci; Mary M Machulda; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2017-06-29       Impact factor: 2.486

2.  Destruction of white matter integrity in patients with mild cognitive impairment and Alzheimer disease.

Authors:  Xiaoyan Sun; David Salat; Kristen Upchurch; Rebecca Deason; Neil Kowall; Andrew Budson
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

3.  HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.

Authors:  Jasmina Boban; Dusko Kozic; Vesna Turkulov; Jelena Ostojic; Robert Semnic; Dajana Lendak; Snezana Brkic
Journal:  Eur Radiol       Date:  2017-03-14       Impact factor: 5.315

Review 4.  Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

Authors:  Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du
Journal:  Ageing Res Rev       Date:  2021-10-29       Impact factor: 10.895

5.  Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single- and multi-voxel proton magnetic resonance spectroscopy study.

Authors:  Zhongxian Yang; Xing Wan; Xinzhu Zhao; Yu Rong; Yi Wu; Zhen Cao; Qiuxia Xie; Min Luo; Yubao Liu
Journal:  Quant Imaging Med Surg       Date:  2021-09

6.  Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.

Authors:  Yi-Jing Chen; Hai-Yang Zheng; Xiu-Xian Huang; Shuang-Xue Han; Dong-Sheng Zhang; Jia-Zuan Ni; Xiao-Yang He
Journal:  CNS Neurosci Ther       Date:  2015-11-20       Impact factor: 5.243

7.  Brain imaging of mild cognitive impairment and Alzheimer's disease.

Authors:  Changhao Yin; Siou Li; Weina Zhao; Jiachun Feng
Journal:  Neural Regen Res       Date:  2013-02-15       Impact factor: 5.135

8.  Effect of radiochemotherapy on the cognitive function and diffusion tensor and perfusion weighted imaging for high-grade gliomas: A prospective study.

Authors:  Yiying Bian; Li Meng; Jianghua Peng; Junfeng Li; Rui Wei; Lei Huo; Huan Yang; Ying Wang; Jun Fu; Liangfang Shen; Jidong Hong
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

Review 9.  In vivo molecular imaging of neuroinflammation in Alzheimer's disease.

Authors:  Aisling Chaney; Steve R Williams; Herve Boutin
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

10.  The metabolic alterations within the normal appearing brain in patients with Hashimoto's thyroiditis are correlated with hormonal changes.

Authors:  Joanna Bladowska; Marta Waliszewska-Prosół; Maria Ejma; Marek Sąsiadek
Journal:  Metab Brain Dis       Date:  2018-09-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.